Address
GIMV NV
37 Karel Oomstraat
2018 Antwerpen
Belgium
Phone
Website
Industry
Recent investment activity
KANDO id: 713
Corporate information
Also known as
Gewestelijke Investeringsmaatschappij voor Vlaanderen
Registration country
Funding rounds
Investment preferences
Focus countries
France
Actual initial investment stage
Series A (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 22 of 22| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
| Ambit Biosciences Inc | A biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer. | Series D | ||||
| Ceres Inc | Plant genomics biotechnology company | N/A | ||||
| ChemoCentryx Inc | N/A | |||||
| CoreOptics GmbH | N/A | |||||
| Coreoptics Inc | Venture | |||||
| Ebuzzing SA | Leading global platform for social video advertising. | N/A USD 14,500,000 (USD 14,500,000) | ||||
|
General Fusion Inc | General Fusion is developing fusion technology to generate affordable, safe and plentiful energy. | Series E | |||
|
GOVECS | Venture Led the round. | ||||
| Interwise Inc | N/A | |||||
| McPhy | Venture | |||||
| Nereus Pharmaceuticals Inc | Series D | |||||
| Nereus Pharmaceuticals Inc | N/A | |||||
| Nereus Pharmaceuticals Inc | Series A | |||||
| Neurotech Pharmaceuticals Inc (Neurotech Inc) | Cell-based drugs for diseases of the eye. | N/A | ||||
| Plexxikon Inc | N/A | |||||
|
PowerInbox Inc | E-mail based, personalized content recommendation platform that increases reader engagement while providing incremental revenue for e-mail publishers. | Series A Initial investment | |||
| Proficient Systems Inc | Enterprise software company. | N/A | ||||
| Prosensa | N/A | |||||
| Santhera Pharmaceuticals AG | Small molecule therapeutics for neuromuscular and metabolic diseases. IPO in November 2006. | N/A | ||||
|
Seedcamp Investments LLP | Early stage mentoring and investment programme for European startups. | N/A | |||
| Ubidyne Inc | Developer of an antenna embedded digital radio tech. | Series B | ||||
| Xanthus Pharmaceuticals Inc | N/A |
Team
| Employee | Position | ||
|---|---|---|---|
| Dirk Boogmans | |||
| Alex Brabers | |||
| Patrick Van Beneden | |||
| Dirk Beeusaert | |||
| Paul De Ridder | |||
| Geert-Jan van Logtestijn | |||
| Marc Vercruysse |